TRCT
BIOR

Tower Research Capital (TRC)’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Tower Research Capital (TRC)’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,353
Closed -$8.93K – 6162
2024
Q2 		$8.93K Buy
1,353
+631
+87% +$4.29K ﹤0.01% 4303
2024
Q1 		$7.94K Sell
722
-1
-0.1% -$11 ﹤0.01% 4110
2023
Q4 		$9.76K Buy
723
+702
+3,343% +$11.4K ﹤0.01% 4347
2023
Q3 		$445 Sell
21
-45
-68% -$1.44K ﹤0.01% 5561
2023
Q2 		$2.53K Buy
66
+14
+27% +$494 ﹤0.01% 5190
2023
Q1 		$1K Sell
52
-192
-79% -$6.51K ﹤0.01% 5733
2022
Q4 		$8K Buy
244
+202
+481% +$14.7K ﹤0.01% 4519
2022
Q3 		$5K Buy
42
+5
+14% +$900 ﹤0.01% 5214
2022
Q2 		$7K Sell
37
-113
-75% -$23.8K ﹤0.01% 4873
2022
Q1 		$44K Buy
150
+94
+168% +$35.7K ﹤0.01% 2844
2021
Q4 		$29K Sell
56
-7
-11% -$5.02K ﹤0.01% 3284
2021
Q3 		$24K Buy
63
+13
+26% +$5.57K ﹤0.01% 3579
2021
Q2 		$44K Buy
50
+16
+47% +$12.2K ﹤0.01% 3138
2021
Q1 		$41K Sell
34
-20
-37% -$27.6K ﹤0.01% 3302
2020
Q4 		$72K Buy
54
+51
+1,700% +$74.8K ﹤0.01% 2701
2020
Q3 		$6K Buy
+3
New +$6.79K ﹤0.01% 4325

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Tower Research Capital (TRC)'s BIOR Position: Q3 2024 in Review

Tower Research Capital (TRC) sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q3 2024, closing a stake of 1,353 shares — an estimated $8.93K sold.

Tower Research Capital (TRC) first reported a position in BIOR in Q3 2020 and held it in 16 quarters. The position peaked at $72K in Q4 2020. 20 funds tracked by Wall St. Rank hold BIOR as of Q3 2024.

  • Tower Research Capital (TRC) reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,353 Biora Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $8.93K.
  • Tower Research Capital (TRC) first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2020 and held it in 16 quarters.
  • Tower Research Capital (TRC)'s Biora Therapeutics, Inc. Common Stock position peaked at $72K in Q4 2020.
  • 20 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2024, filed 14 Nov 2024.